E-BUZZ ME Logo
ScienceTechnical Deep Dive

The 'Mitch' Switch: Scientists Identify Protein That Burns Fat and Halts New Fat Cell Growth

Published
The 'Mitch' Switch: Scientists Identify Protein That Burns Fat and Halts New Fat Cell Growth
2 min read322 words

The Gist

Researchers at the Weizmann Institute have discovered that disabling the MTCH2 protein forces cells to prioritize fat as fuel while preventing the formation of new fat-storing cells.

Researchers at the Weizmann Institute of Science have identified a potential breakthrough in obesity treatment: a protein switch named MTCH2, or "Mitch," that regulates how the body manages energy and stores fat. According to a study published in the EMBO Journal, disabling this protein in human cells effectively supercharges metabolism by forcing cells to burn fat more aggressively.

A Catalyst for Fat Metabolism

The research team, led by Prof. Atan Gross and doctoral student Sabita Chourasia, found that removing Mitch disrupts the efficiency of mitochondria—the cell's power plants. While mitochondrial inefficiency might sound counterproductive, it creates a constant state of energy shortage. To compensate, cells must consume more fuel, specifically shifting their preference toward breaking down lipids and carbohydrates.

In laboratory tests, human cells lacking the Mitch protein showed a dramatic increase in cellular respiration. More importantly, these cells shifted their primary fuel source from proteins and sugars to fat, effectively depleting fat stores within the cell membranes to meet their energy demands.

Blocking New Fat Formation

Beyond increasing energy expenditure, the study revealed a secondary benefit: the suppression of adipogenesis, or the creation of new fat cells. Normally, progenitor cells differentiate into mature fat cells to store excess energy. However, without the Mitch protein, the environment within these cells becomes hostile to fat synthesis. The resulting energy shortage and suppressed gene expression prevent these immature cells from growing and developing into fat-storing units.

Implications for Future Obesity Treatments

This discovery builds on previous animal studies where mice lacking Mitch in their muscles were not only resistant to obesity but also displayed superior athletic endurance and heart function. This suggests that targeting the Mitch protein could lead to a new generation of weight-loss therapies that avoid a common pitfall of current drugs: the loss of muscle mass. By encouraging the body to burn fat while potentially supporting muscle fiber development, Mitch-based treatments could offer a more balanced approach to metabolic health.

Related Stories

Semantically matched articles, ranked by topic overlap and freshness.

AI Aids Stanford Researchers in Discovering Natural Weight Loss Molecule
Science71%

AI Aids Stanford Researchers in Discovering Natural Weight Loss Molecule

Stanford scientists have identified a natural molecule that mimics the weight-loss effects of Ozempic with fewer side effects by targeting specific brain regions.

Sulfur-Based Compound Identified as Potential Breakthrough for Aging Muscle Repair
Science69%

Sulfur-Based Compound Identified as Potential Breakthrough for Aging Muscle Repair

Researchers have discovered a compound named LASSS that protects proteins essential for muscle recovery, offering hope for combating age-related muscle loss.

Biological Age Linked to Weight Loss Success in New Study
Science69%

Biological Age Linked to Weight Loss Success in New Study

A recent study suggests that individuals with a biological age younger than their chronological age may lose more weight when following calorie-restricted diets.

GLP-1 Weight Loss Drugs Linked to Increased Risk of Hair Loss
Science67%

GLP-1 Weight Loss Drugs Linked to Increased Risk of Hair Loss

A large-scale study reveals that popular GLP-1 medications like Ozempic and Mounjaro may carry a higher risk of alopecia compared to other diabetes treatments.

The Economic Hurdles Facing GLP-1 Weight Loss Drugs
Science66%

The Economic Hurdles Facing GLP-1 Weight Loss Drugs

While drugs like Ozempic and Wegovy offer significant health benefits, their high costs pose a major challenge to insurance budgets and patient access.

Longevity-Linked APOE2 Gene Found to Shield Brain from Aging and Alzheimer’s
Science64%

Longevity-Linked APOE2 Gene Found to Shield Brain from Aging and Alzheimer’s

Researchers have discovered that the APOE2 gene variant protects neurons by reducing DNA damage and enhancing stress recovery, offering a potential blueprint for new Alzheimer’s therapies.

New Experimental Antiviral Pill Shows Promise in Halting Measles Transmission
Science63%

New Experimental Antiviral Pill Shows Promise in Halting Measles Transmission

A breakthrough antiviral treatment has successfully prevented the spread of a measles-like virus in animal trials, offering a potential new tool to contain future outbreaks.

Self-Repairing Bio-Textiles: Scientists Create Clothing From Living Fungi
Science62%

Self-Repairing Bio-Textiles: Scientists Create Clothing From Living Fungi

Researchers have developed a revolutionary biodegradable textile using the parasitic fungus Cordyceps militaris that can clean and repair itself.